Cargando…

Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma

SIMPLE SUMMARY: Almost all patients with glioblastoma (GBM) eventually relapse, mainly due to adaptive and acquired resistance that results from tumour heterogeneity and its relatively immune-depleted (“cold”) microenvironment. High levels of programmed death ligand-1 (PD-L1) have been associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Gitanjali, Braga, Marta C., Da Pieve, Chiara, Szopa, Wojciech, Starzetz, Tatjana, Plate, Karl H., Kaspera, Wojciech, Kramer-Marek, Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295898/ https://www.ncbi.nlm.nih.gov/pubmed/37370741 http://dx.doi.org/10.3390/cancers15123131

Ejemplares similares

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
por: Szopa, Wojciech, et al.
Publicado: (2017)

Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
por: Niedbała, Marcin, et al.
Publicado: (2022)

Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment
por: Burley, Thomas A., et al.
Publicado: (2018)

New Fully Automated Preparation of High Apparent Molar Activity (68)Ga-FAPI-46 on a Trasis AiO Platform
por: Da Pieve, Chiara, et al.
Publicado: (2022)

Correction: Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy
por: Mączyńska, Justyna, et al.
Publicado: (2022)

Imaging PD-L1 Expression with ImmunoPET
por: Truillet, Charles, et al.
Publicado: (2017)

Preservation of the Hypoxic Transcriptome in Glioblastoma Patient-Derived Cell Lines Maintained at Lowered Oxygen Tension
por: Gozdz, Agata, et al.
Publicado: (2022)

Efficient PD-L1 imaging of murine glioblastoma with FUS-aided immunoPET by leveraging FcRn-antibody interaction
por: Chevaleyre, Céline, et al.
Publicado: (2023)

Immuno-Imaging (PET/SPECT)–Quo Vadis?
por: Kramer, Carsten S., et al.
Publicado: (2022)

Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
por: Burley, Thomas A., et al.
Publicado: (2019)

Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [(18)F]AlF-Affibody Conjugates
por: Da Pieve, Chiara, et al.
Publicado: (2020)

Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016)

Morphological and Hemodynamic Risk Factors for Middle Cerebral Artery Aneurysm: a Case-Control Study of 190 Patients
por: Kaspera, Wojciech, et al.
Publicado: (2020)

Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography
por: Ruiz-López, Eduardo, et al.
Publicado: (2021)

ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022)

Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma
por: Nisnboym, Michal, et al.
Publicado: (2023)

Dosimetry Prediction for Clinical Translation of (64)Cu-Pembrolizumab ImmunoPET Targeting Human PD-1 Expression
por: Natarajan, Arutselvan, et al.
Publicado: (2018)

Endoscopic approach to the resection of adenoid cystic carcinoma of paranasal sinuses and nasal cavity: case report and own experience
por: Wardas, Piotr, et al.
Publicado: (2015)

Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
por: Kim, Jin Su
Publicado: (2016)

Immuno-PET Molecular Imaging of RANKL in Cancer
por: Dewulf, Jonatan, et al.
Publicado: (2021)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
por: Bridoux, Jessica, et al.
Publicado: (2020)

Immuno-imaging of ICAM-1 in tumours by SPECT
por: Mosley, Michael, et al.
Publicado: (2020)

PD‐L1 and beyond: Immuno‐oncology in cytopathology
por: Iaccarino, Antonino, et al.
Publicado: (2021)

PD-L1 testing by immunohistochemistry in immuno-oncology
por: Vranic, Semir, et al.
Publicado: (2023)

Wall shear stress gradient is independently associated with middle cerebral artery aneurysm development: a case-control CFD patient-specific study based on 77 patients
por: Zimny, Mikołaj, et al.
Publicado: (2021)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

(89)Zr Immuno-PET Imaging of Tumor PD-1 Reveals That PMA Upregulates Lymphoma PD-1 through NFκB and JNK Signaling
por: Jung, Kyung-Ho, et al.
Publicado: (2022)

Application of Immuno-PET in Antibody–Drug Conjugate Development
por: Carmon, Kendra S., et al.
Publicado: (2018)

Immuno-PET: Design options and clinical proof-of-concept
por: Lugat, Alexandre, et al.
Publicado: (2022)

The role of the immuno-inflammatory response in patients after cardiac arrest
por: Samborska-Sablik, Anna, et al.
Publicado: (2011)

The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology
por: Schöniger, Sandra, et al.
Publicado: (2022)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021)

Targeting Stereotactic Body Radiotherapy on Metabolic PET- and Immuno-PET-Positive Vertebral Metastases
por: Pichon, Baptiste, et al.
Publicado: (2020)

Evaluation of (124)I-JS001 for hPD1 immuno-PET imaging using sarcoma cell homografts in humanized mice
por: Huang, Haifeng, et al.
Publicado: (2020)

Aberrantly Expressed RECQL4 Helicase Supports Proliferation and Drug Resistance of Human Glioma Cells and Glioma Stem Cells
por: Król, Sylwia K., et al.
Publicado: (2020)

Immunomodulatory activity of IR700-labelled affibody targeting HER2
por: Mączyńska, Justyna, et al.
Publicado: (2020)

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c45a9n9donj22iq8fkppkkkcsk